Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$25.8 - $39.97 $45,640 - $70,706
1,769 Added 28.05%
8,075 $239,000
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $132,047 - $239,691
6,306 New
6,306 $225,000
Q3 2022

Nov 08, 2022

BUY
$43.66 - $61.0 $181,189 - $253,150
4,150 New
4,150 $223,000
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $366,239 - $490,086
-3,708 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $47,201 - $71,242
430 Added 13.12%
3,708 $460,000
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $399,667 - $563,448
-3,146 Reduced 48.97%
3,278 $500,000
Q4 2020

Feb 11, 2021

BUY
$99.96 - $135.93 $240,203 - $326,639
2,403 Added 59.76%
6,424 $827,000
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $322,966 - $449,547
4,021 New
4,021 $449,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.